注冊以創建關於儀器的通知
你所追隨的作者的經濟活動和內容
免費註冊 已有帳戶? 登入
Genenta Science SpA是一家意大利的公司,從事臨床階段的生物技術研究。該公司專注於開發基於慢病毒基因和細胞療法治療癌症。它使用基於基因細胞因子傳遞來激活腫瘤內的免疫系統,提供抗腫瘤反應。該公司不僅在本地開展業務,也在包括美國在內的全球市場開展業務。
名稱 | 年齡 | 成立於 | 主旨 |
---|---|---|---|
Pierluigi Paracchi | 51 | 2014 | Vice Chairman of the Board, CEO & GM |
Bernard Rudolph Gentner | 49 | - | Co-Founder & Member of the Executive Scientific Board |
Luigi Naldini | 65 | - | Co-Founder & Chairman of the Executive Scientific Board |
Miriam Merad | - | 2021 | Member of Scientific Advisory Board |
Wolf-Herve Fridman | - | 2021 | Member of Scientific Advisory Board |
Richard A. Flavell | 78 | 2021 | Member of Scientific Advisory Board |
Carlo-Alberto Nicchio | 49 | 2021 | Chairman of the Board of Statutory Auditors |
Michele De Palma | - | - | Member of Scientific Advisory Board |
Lisa M. Coussens | - | - | Member of Scientific Advisory Board |
Kenneth C. Anderson | 73 | - | Member of Scientific Advisory Board |
Jacopo Doveri | 51 | 2021 | Statutory Auditor |
Patrick Yung Wen | - | 2021 | Member of Scientific Advisory Board |
Cesare Lazzaroni | 73 | 2021 | Statutory Auditor |
你確定要封鎖 %USER_NAME%?
此舉將會令你與 %USER_NAME% 之間無法看見對方的Investing.com貼文。
%USER_NAME% 已成功加入你的封鎖清單
你剛解除此人的封鎖,必須等候 48 小時後才可再次封鎖。
我覺得這個評論是:
謝謝!
您的報告已被發送到我們的版主審核